Weiland Robert J. 4
4 · Pacira Pharmaceuticals, Inc. · Filed Jun 6, 2018
Insider Transaction Report
Form 4
Weiland Robert J.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2018-06-04$33.02/sh−373$12,316→ 5,088 total
Footnotes (2)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]Includes 339 and 258 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017 and December 2017, respectively.